期刊文献+

福建省2000—2012年AFP阳性病例流行病学特征 被引量:5

Epidemiological characteristics of AFP cases with virus positive in Fujian(2000—2012)
原文传递
导出
摘要 目的了解福建省在无脊髓灰质炎后,病毒分离阳性的AFP病例流行特征。方法对2000—2012年病毒分离阳性的AFP病例进行流行病学分析。结果 13年共报告AFP病例1 822例,年均发病率1.70/10万。共采集1 807例标本进行病毒分离,PV阳性4.6%,NPEV阳性11.1%,PV+NPEV混合阳性0.4%,阴性83.9%。PV组中,<1岁占44.6%,流动人口占10.8%,未全程免疫占24.1%,残留麻痹率27.7%,均高于其他组;NPEV组中,<1岁仅占9.5%,流动人口仅占2.5%,未全程免疫仅占9.0%,残留麻痹率仅12.4%。结论在维持无脊灰阶段,需继续提高口服脊灰疫苗(OPV)覆盖率,重点是流动儿童和边远山区儿童。加强NPEV防控亦可减少AFP病例及致残率。 Obejective To analyze epidemiological characteristics of AFP cases with virus positive in Fujian after achieving polio-free. Methods The AFP data was analyzed descriptively from 2000 to 2012. Results Totally 1 822 AFP cases' were reported and mean incidence was 1.70/10s during the years. The 1 807 stool specimens Were collected and detected. The isolation rate of vaccine-associated poliovirus (PV) was 4. 6%, of non-poliovirus (NPEV) was 11.1%, of PV mixing with NPEV(PV+NPEV) was 0.4%, and negative rate was 83.9%. In PV group, 44.6% cases were 〈1 year old, floating population was 10.8%, 24.1% cases didn't get full courses vaccination, 27.7% cases were residual paralysis. In NPEV group, 9.5% cases were〈1 years old, floating population was 2.5%, 9.0% cases didn't get full courses vaccination, 12.4% cases were residual paralysis only. Conclusions The OPV coverage should be improved and emphasized on the floating children and rural remote areas to maintain the polio-free status. The NPEV control is effective on decreasing AFP and residual paralysis cases.
出处 《海峡预防医学杂志》 CAS 2014年第1期12-14,17,共4页 Strait Journal of Preventive Medicine
基金 福建省自然科学基金资助项目(No.2011J01125)
关键词 脊髓灰质炎病毒(PV) 急性弛缓性麻痹(AFP) 病毒分离 非脊髓灰质炎肠道病毒(NPEV) Poliovirus(PV) Acute Flaccid Paralysis (AFP) Virus Isolate Non-polio enteroviruses (NPEV)
  • 相关文献

参考文献8

二级参考文献33

  • 1张礼璧.实行新的脊髓灰质炎病例分类方法的意义[J].中国计划免疫,1995,1(1):5-6. 被引量:9
  • 2李杰,张礼壁,米山彻夫,侯晓辉,郑红,方勇,原稔,荻原昭夫.中国脊髓灰质炎病毒疫苗株基因变异的分析[J].病毒学报,1996,12(4):291-298. 被引量:17
  • 3[1]Horaud F,Albert B.Sabin and the development of oral polio vaccine[J].Biological,1993,21:311-316.
  • 4[2]Kew O M,Nottay B K,Hatch M H,et al.Multiple genetic changes can occur in the oral polio vaccines upon replication in humans[J].J Gen Virol,1998,156:337-347.
  • 5[3]Balanat J,Guillot S,Candrea A,et al.The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay[J].Virology,1991,184:645-654.
  • 6[4]Bouchard M J,Lam D H,Racaniello V R,et al.Determinants of Attenuation and Temperature Sensitivity in the Type Ⅰ Poliovirus Sabin Vaccine[J].J Virology,1995,69(8):4972-4978.
  • 7[5]Ren R B,Moss E G,Racaniello V R,et al.Identification of Two Determinants that Attenuate Vaccine-Related Type Ⅱ Poliovirus[J].J Virology,1991,65(3):1377-1382.
  • 8[6]Almond J W,Westrop G D,Evans D M A,et al.Studies on the Attenuation of the Sabin Type Ⅲ Oral Polio Vaccine[J].J Virol Meth,1987,17:183-189.
  • 9[7]Joce R,Wood D,Brown D,et al.Paralytic Poliomyelitis in England and Wales,1985-91[J].Br Med J,1992,305:79-82.
  • 10[8]Almond J W.The Attenuation of Poliovirus Neurovirulence[J].Microbiol,1987,41:153-180.

共引文献145

同被引文献24

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部